Citation Impact
Citing Papers
Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice
2006
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
2010 Standout
A novel ATP‐binding cassette transporter from Leishmania is involved in transport of phosphatidylcholine analogues and resistance to alkyl‐phospholipids
2007
Moving out: from sterol transport to drug resistance – the ABCG subfamily of efflux pumps
2011
Regulation of macrophage function in inflammation and atherosclerosis
2008
Sirtuins as regulators of metabolism and healthspan
2012 Standout
ABCG1 and ABCG4 are coexpressed in neurons and astrocytes of the CNS and regulate cholesterol homeostasis through SREBP-2
2007
The re-emergence of natural products for drug discovery in the genomics era
2015 Standout
Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice
2013 Standout
Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease
2006
Role of cholesterol and lipid organization in disease
2005 Nature
Phospholipid Flippases
2006
AMPK: guardian of metabolism and mitochondrial homeostasis
2017 Standout
Effects of Torcetrapib in Patients at High Risk for Coronary Events
2007 Standout
LDL particle subspecies are distinct in their capacity to mediate free cholesterol efflux via the SR-BI/Cla-1 receptor
2006
ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet
2008
Sirtuin-7 Inhibits the Activity of Hypoxia-inducible Factors
2013 StandoutNobel
Deletion ofAbca7Increases Cerebral Amyloid-β Accumulation in the J20 Mouse Model of Alzheimer's Disease
2013
Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function
2009 Standout
Hypomorphic Mutation in the Site-1 Protease Mbtps1 Endows Resistance to Persistent Viral Infection in a Cell-Specific Manner
2011 StandoutNobel
Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo
2007
Liver X receptors as integrators of metabolic and inflammatory signaling
2006
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
High-density lipoproteins as therapeutic targets
2005
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Late onset Alzheimer’s disease genetics implicates microglial pathways in disease risk
2017
Translating molecular discoveries into new therapies for atherosclerosis
2008 Nature
Expression and Regulation of Multiple Murine ATP-binding Cassette Transporter G1 mRNAs/Isoforms That Stimulate Cellular Cholesterol Efflux to High Density Lipoprotein
2004
Macrophage Differentiation to Foam Cells
2005
The Novel Anticancer Agent JNJ-26854165 Induces Cell Death through Inhibition of Cholesterol Transport and Degradation of ABCA1
2013
Atherosclerosis: current pathogenesis and therapeutic options
2011 Standout
Cholesterol, inflammation and innate immunity
2015
C. elegans Major Fats Are Stored in Vesicles Distinct from Lysosome-Related Organelles
2009 StandoutNobel
Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARα, β/δ, and γ
2004
Hepatocyte Polarity
2012
Accurate Prediction of the Functional Significance of Single Nucleotide Polymorphisms and Mutations in the ABCA1 Gene
2005
Predicting the Functional Effect of Amino Acid Substitutions and Indels
2012 Standout
Molecular regulation of macrophage reverse cholesterol transport
2007
ABCG1 Redistributes Cell Cholesterol to Domains Removable by High Density Lipoprotein but Not by Lipid-depleted Apolipoproteins
2005
Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities
2021 Standout
Macrophages in atherosclerosis: a dynamic balance
2013 Standout
Cholesterol efflux pathways and other potential mechanisms involved in the athero‐protective effect of high density lipoproteins
2008
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
2007 Standout
Emerging Strategies for Increasing High-Density Lipoprotein
2006
Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: Roles of pre β-HDL, phospholipid transfer protein and cholesterol esterification
2007
The immune system in atherosclerosis
2011 Standout
Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease
2010 Standout
Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR
2012
HDL Biogenesis, Remodeling, and Catabolism
2014
Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors
2020 StandoutNobel
Targeting Cholesteryl Ester Transfer Protein for the Prevention and Management of Cardiovascular Disease
2006
Update on strategies to increase HDL quantity and function
2009
Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities
2010 Standout
High-density lipoprotein heterogeneity and function in reverse cholesterol transport
2010
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol
2008
Membrane lipids: where they are and how they behave
2008 Standout
The mystery of membrane organization: composition, regulation and roles of lipid rafts
2017 Standout
Differential Regulation of Lipoprotein and Hepatitis C Virus Secretion by Rab1b
2017 StandoutNobel
Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis
2011
Role of CETP inhibitors in the treatment of dyslipidemia
2004
ABC lipid transporters: Extruders, flippases, or flopless activators?
2005
Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I
2005
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Current understanding of the metabolism and biological actions of HDL
2005
The Hallmarks of Aging
2013 Standout
Scavenger receptor class B Type I (SR-BI) assembles into detergent-sensitive dimers and tetramers
2006
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
2011 Standout
ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation
2005
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
2011 Standout
Mechanisms and regulation of cholesterol homeostasis
2019
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
2010 StandoutNature
HDL as a target in the treatment of atherosclerotic cardiovascular disease
2005
Sterol Regulatory Element-binding Protein-2- and Liver X Receptor-driven Dual Promoter Regulation of Hepatic ABC Transporter A1 Gene Expression
2007
Bifidobacteria can protect from enteropathogenic infection through production of acetate
2011 StandoutNature
Stem cell-derived polarized hepatocytes
2020 StandoutNobel
Lipid flippases and their biological functions
2006
Functionally Defective High-Density Lipoprotein: A New Therapeutic Target at the Crossroads of Dyslipidemia, Inflammation, and Atherosclerosis
2006 Standout
Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice
2007
Disordered haematopoiesis and athero-thrombosis
2016
HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway
2006
The amyloid hypothesis of Alzheimer's disease at 25 years
2016 Standout
Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARα, β/δ, and γ
2004
Apolipoprotein A-I Mimetic Peptides
2005
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Macrophage LRP-1 Controls Plaque Cellularity by Regulating Efferocytosis and Akt Activation
2010
HDL, ABC Transporters, and Cholesterol Efflux: Implications for the Treatment of Atherosclerosis
2008
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I
2005
Human immunodeficiency virus infection and macrophage cholesterol metabolism
2006
Role of HDL, ABCA1, and ABCG1 Transporters in Cholesterol Efflux and Immune Responses
2009
Regulation of Macrophage Functions by PPAR-α, PPAR-γ, and LXRs in Mice and Men
2008
Fat and Beyond: The Diverse Biology of PPARγ
2008 Standout
ABCA1 and ABCG1 Protect Against Oxidative Stress–Induced Macrophage Apoptosis During Efferocytosis
2010
Macrophage Reverse Cholesterol Transport
2006
High-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density Lipoprotein
2007 StandoutNobel
ATP-binding cassette transporter G4 is highly expressed in microglia in Alzheimer's brain
2008
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1
2007
Diabetic Dyslipidemia
2006
LXRS AND FXR: The Yin and Yang of Cholesterol and Fat Metabolism
2005
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
Inflammation and autoimmunity caused by a SHP1 mutation depend on IL-1, MyD88, and a microbial trigger
2008 StandoutNobel
Thyroid Hormone Regulation of Metabolism
2014 Standout
Interleukin‐10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice
2010
Combined Deletion of Macrophage ABCA1 and ABCG1 Leads to Massive Lipid Accumulation in Tissue Macrophages and Distinct Atherosclerosis at Relatively Low Plasma Cholesterol Levels
2007
Increased Inflammatory Gene Expression in ABC Transporter–Deficient Macrophages
2008
Decreased Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice Transplanted With Abcg1 −/− Bone Marrow
2006
The Metabolic Syndrome
2008 Standout
Endothelial Cell Metabolism in Normal and Diseased Vasculature
2015
Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis
2016 Standout
AMPK regulation of fatty acid metabolism and mitochondrial biogenesis: Implications for obesity
2012
Cholesterol Synthesis Inhibition Elicits an Integrated Molecular Response in Human Livers Including Decreased ACAT2
2008 StandoutNobel
New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport
2005
The Formation and Function of Plant Cuticles
2013 Standout
Drug Resistance in Leishmaniasis
2006 Standout
Physiology of Microglia
2011 Standout
Cholesterol Sensing, Trafficking, and Esterification
2006
Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants
2009 StandoutNobel
Works of Debin Lan being referenced
ATP-binding Cassette Transporter A7 (ABCA7) Binds Apolipoprotein A-I and Mediates Cellular Phospholipid but Not Cholesterol Efflux
2003
Sirtuin 1 (SIRT1) Deacetylase Activity Is Not Required for Mitochondrial Biogenesis or Peroxisome Proliferator-activated Receptor-γ Coactivator-1α (PGC-1α) Deacetylation following Endurance Exercise
2011
Interaction with PDZK1 Is Required for Expression of Organic Anion Transporting Protein 1A1 on the Hepatocyte Surface
2005
ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins
2004